MetaADEDB 2.0 @ LMMD
alcaftadine
(MWTBKTRZPHJQLH-UHFFFAOYSA-N)
Structure
SMILES
O=Cc1cnc2n1CCc1c(C2=C2CCN(CC2)C)cccc1
Type(s)
Approved
ATC code(s)
S01GX11
Molecular Formula:
C19H21N3O
Molecular Weight:
307.390
Log P:
2.7171
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
0
TPSA:
38.13
CAS Number(s):
147084-10-4
Synonym(s)
1.
alcaftadine
External Link(s)
MeSHC557708
PubChem Compound19371515
ChEBI71023
CHEMBLCHEMBL1201747
DrugBankDB06766
DrugCentral4165
IUPHAR/BPS Guide to PHARMACOLOGY7587
KEGGdr:D06552
Therapeutic Target DatabaseD0O7JW
ZINC11726211
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Eye irritationFAERS: 86SIDER
US FAERS
2Eye painFAERS: 48US FAERS
3HypersensitivityFAERS: 30US FAERS
4HeadacheFAERS: 15SIDER
US FAERS
5ConjunctivitisFAERS: 13US FAERS
6Drug ineffectiveFAERS: 13US FAERS
7Eye inflammationFAERS: 13US FAERS
8Instillation site painFAERS: 12US FAERS
9FatigueFAERS: 11US FAERS
10SomnolenceFAERS: 11US FAERS
11Foreign body sensation in eyesFAERS: 10US FAERS
12PhotophobiaFAERS: 10US FAERS
13ErythemaFAERS: 9US FAERS
14Eyelids pruritusFAERS: 6US FAERS
15Activities of daily living impairedFAERS: 5US FAERS
16BlepharitisFAERS: 5US FAERS
17DizzinessFAERS: 5US FAERS
18Feeling abnormalFAERS: 5US FAERS
19Eyelid exfoliationFAERS: 4US FAERS
20Instillation site erythemaFAERS: 4US FAERS
21NauseaFAERS: 4US FAERS
22AstheniaFAERS: 3US FAERS
23Burning sensationFAERS: 3US FAERS
24Eye InfectionFAERS: 3US FAERS
25Eye allergyFAERS: 3US FAERS
26Impaired driving abilityFAERS: 3US FAERS
27MydriasisFAERS: 3US FAERS
28PainFAERS: 3SIDER
US FAERS
29Adverse eventFAERS: 2US FAERS
30AnxietyFAERS: 2US FAERS
31Chemical burns of eyeFAERS: 2US FAERS
32Conjunctival irritationFAERS: 2US FAERS
33DiplopiaFAERS: 2US FAERS
34DysgeusiaFAERS: 2US FAERS
35EpistaxisFAERS: 2US FAERS
36Inappropriate schedule of drug administrationFAERS: 2US FAERS
37Incorrect dose administeredFAERS: 2US FAERS
38InflammationFAERS: 2US FAERS
39KeratitisFAERS: 2US FAERS
40LethargyFAERS: 2US FAERS
41Ocular discomfortFAERS: 2US FAERS
42PruritusFAERS: 2US FAERS
43Throat irritationFAERS: 2US FAERS
44AphoniaFAERS: 1US FAERS
45Application site painFAERS: 1US FAERS
46AsthenopiaFAERS: 1US FAERS
47Back PainFAERS: 1US FAERS
48Contact lens intoleranceFAERS: 1US FAERS
49Corneal erosionFAERS: 1US FAERS
50Corneal lesionFAERS: 1US FAERS
51CycloplegiaFAERS: 1US FAERS
52Dacryostenosis acquiredFAERS: 1US FAERS
53DermatitisFAERS: 1US FAERS
54Expired product administeredFAERS: 1US FAERS
55Eye BurnsFAERS: 1US FAERS
56Eyelid irritationFAERS: 1US FAERS
57Eyelid painFAERS: 1US FAERS
58Feeling ColdFAERS: 1US FAERS
59FlushingFAERS: 1US FAERS
60Instillation site abnormal sensationFAERS: 1US FAERS
61Instillation site burnFAERS: 1US FAERS
62Instillation site pruritusFAERS: 1US FAERS
63Intentional product misuseFAERS: 1US FAERS
64Joint swellingFAERS: 1US FAERS
65Medication residueFAERS: 1US FAERS
66MyalgiaFAERS: 1US FAERS
67Noninfective conjunctivitisFAERS: 1US FAERS
68Pain of skinFAERS: 1US FAERS
69PalpitationsFAERS: 1US FAERS
70Paranasal sinus hypersecretionFAERS: 1US FAERS
71PneumoniaFAERS: 1US FAERS
72PregnancyFAERS: 1US FAERS
73Product quality issueFAERS: 1US FAERS
74Product taste abnormalFAERS: 1US FAERS
75Purulent dischargeFAERS: 1US FAERS
76Rash erythematousFAERS: 1US FAERS
77Reaction to preservativesFAERS: 1US FAERS
78Secretion dischargeFAERS: 1US FAERS
79SneezingFAERS: 1US FAERS
80Sudden onset of sleepFAERS: 1US FAERS
81Tension HeadacheFAERS: 1US FAERS
82UrticariaFAERS: 1US FAERS
83Visual ImpairmentFAERS: 1US FAERS
84VomitingFAERS: 1US FAERS
85Eye RednessSIDER
86InfluenzaSIDER
87NasopharyngitisSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.